Gough SC, Bode B, Woo V, et al
Sermorelin and Weight Loss: A Perfect Partner for GLP-1 At Peak Medical, many patients are turning to GLP-1 weight loss medications such as Semaglutide and Tirzepatide
Last Published 07.01.2026 Effective Date: 07.01.2026 This policy addresses the use of interleukin-5 (IL-5) antagonists, including Cinqair (reslizumab), Fasenra (benralizumab), and Nucala (mepolizumab)
The advisory board is meeting for two sessions
inflammatory cytokines (TNF-/IL-6) promote platelet aggregation and microthrombus formation in liver sinusoids [77]
For patients with health conditions like heart disease who are starting treatment with any GLP-1 medication, close monitoring by healthcare providers is important